
Emerging SME Services · NSE
Incorporated in 2017, Sunrest Lifescience Limited offers a wide range of healthcare and personal care products, including capsules, tablets, syrup, ointment, gel, mouthwash, solution, suspension, dry powders, and toothpaste. Its portfolio covers medicines across multiple therapeutic categories like anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-protozoal, anti-histamine, anti-hypertensive, cosmetics, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory. With 18 registered trademarks covering 32 products, Sunrest Lifescience is focused on delivering high-quality and effective formulations to its customers.
Price Band
₹84
Issue Size
₹10.85 Cr
Lot Size
1600 shares
GMP
+6.0%
Est. Listing
₹89
at current GMP
Subscribed
47.51x
overall
Open
7 Nov 2023
Close
9 Nov 2023
Allotment
15 Nov 2023
Refund
16 Nov 2023
Demat Credit
17 Nov 2023
Listing
20 Nov 2023
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹84
Band: ₹84
Estimated Listing Price
₹89
Upper price + GMP
Lot Size
1600 shares
Min investment ₹1,34,400
Estimated Profit / Lot
₹8,000
1600 × ₹5
Grey Market Premium trend
+₹5
▲ 0 today
Updated 12 months ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 17 Mar 2025 | +₹5 | 6.0% | ₹89 |
| 5 Nov 2025 | +₹5 | 6.0% | ₹89 |
GMP is unofficial market data. Not a guarantee of listing performance.
Sunrest Lifescience Limited is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹10.85 Crores. The shares are offered at a price band of ₹84 to ₹84 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,34,400 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Skyline Financial Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-11-17, while un-allotted funds or UPI block mandates will be released on 2023-11-16.
The latest grey market premium for Sunrest Lifescience Limited IPO is ₹5, which indicates an expected listing price of ₹89.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.